BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35331180)

  • 1. The abdominal-transhiatal surgical approach versus the thoracoabdominal surgical approach in Siewert type II adenocarcinoma of the esophagogastric junction: protocol for a multicenter prospective, open, parallel, and randomized controlled trial.
    Song Q; Li X; Wu D; Li S; Xie T; Lu Y; Zhang L; Xu Z; Liu L; Guo X; Wang X
    BMC Cancer; 2022 Mar; 22(1):318. PubMed ID: 35331180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of thoracoabdominal versus abdominal-transhiatal surgical approaches in Siewert type II adenocarcinoma at the esophagogastric junction: Protocol for a prospective multicenter randomized controlled trial.
    Yue C; Mo Z; Wu X; Wang Y; Yang Q; Wang W; Zhou H; Gao R; Ji P; Dong D; Zhang Y; Ji G; Li X
    Front Oncol; 2023; 13():1091615. PubMed ID: 37064105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
    BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
    Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kuwata T; Tokunaga M; Kaito A; Watanabe M; Tonouchi A; Sato R; Nagino M
    Surg Endosc; 2021 Jan; 35(1):340-348. PubMed ID: 32025923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of short-term surgical outcomes between complete mesenteric resection and traditional transhiatal laparoscopic surgery for Siewert type II/III esophagogastric junction adenocarcinoma.
    Zhu TY; Deng XM; Wang GJ; Gao BL; Li RX; Wang JT
    Langenbecks Arch Surg; 2022 Dec; 407(8):3811-3818. PubMed ID: 36214868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term and Long-Term Outcomes Following Transhiatal versus Right Thoracoabdominal Resection of Siewert Type II Adenocarcinoma of the Esophagogastric Junction.
    Xing J; Liu M; Xu K; Gao P; Tan F; Yao Z; Zhang N; Yang H; Zhang C; Cui M; Su X
    Cancer Manag Res; 2020; 12():11813-11821. PubMed ID: 33244264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of robotic surgery for Siewert type II/III adenocarcinoma of esophagogastric junction: transhiatal robotic versus laparoscopic approach.
    Nishi M; Wada Y; Yoshikawa K; Takasu C; Tokunaga T; Nakao T; Kashihara H; Yoshimoto T; Shimada M
    BMC Surg; 2023 May; 23(1):128. PubMed ID: 37194030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracoabdominal versus transhiatal surgical approaches for adenocarcinoma of the esophagogastric junction-a systematic review and meta-analysis.
    Heger P; Blank S; Gooßen K; Nienhüser H; Diener MK; Ulrich A; Mihaljevic AL; Schmidt T
    Langenbecks Arch Surg; 2019 Feb; 404(1):103-113. PubMed ID: 30607534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transhiatal versus transthoracic surgical approach for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction: a meta-analysis.
    Wu H; Shang L; Du F; Fu M; Liu J; Fang Z; Li L
    Expert Rev Gastroenterol Hepatol; 2020 Nov; 14(11):1107-1117. PubMed ID: 32757864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic-assisted
    Song QY; Li XG; Zhang LY; Wu D; Li S; Zhang BL; Xu ZY; Wu RL; Guo X; Wang XX
    World J Gastrointest Surg; 2022 Apr; 14(4):304-314. PubMed ID: 35664362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic versus open gastrectomy for Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis.
    Liao C; Feng Q; Xie S; Chen J; Shi Y
    Surg Endosc; 2021 Feb; 35(2):860-871. PubMed ID: 32076857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?
    Blank S; Schmidt T; Heger P; Strowitzki MJ; Sisic L; Heger U; Nienhueser H; Haag GM; Bruckner T; Mihaljevic AL; Ott K; Büchler MW; Ulrich A
    Gastric Cancer; 2018 Mar; 21(2):303-314. PubMed ID: 28685209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node dissection for Siewert II esophagogastric junction adenocarcinoma: A retrospective study of 3 surgical procedures.
    Duan XF; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
    Medicine (Baltimore); 2017 Feb; 96(7):e6120. PubMed ID: 28207537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical strategy for adenocarcinoma of esophagogastric junction].
    Lu Y; Zhang K; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.